Literature DB >> 14629997

Iridoid glucosides from Strychnos nux-vomica.

Xiaozhe Zhang1, Qing Xu, Hongbin Xiao, Xinmiao Liang.   

Abstract

From seeds of Strychnos nux-vomica three iridoids, 6'-O-acetylloganic acid, 4'-O-acetylloganic acid and 3'-O-acetylloganic acid were isolated together with two known iridoid glucosides, loganic acid and 7-O-acetylloganic acid. The structures of the compounds were established by ESI-MS and by 1D and 2D NMR spectroscopic methods.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14629997     DOI: 10.1016/s0031-9422(03)00501-6

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  5 in total

1.  Rapid preparative separation of six bioactive compounds from Gentiana crassicaulis Duthie ex Burk. using microwave-assisted extraction coupled with high-speed counter-current chromatography.

Authors:  Jinru Liang; Yoichiro Ito; Xinxin Zhang; Jiao He; Wenji Sun
Journal:  J Sep Sci       Date:  2013-12       Impact factor: 3.645

2.  Antiproliferative Alkaloids from Alangium longiflorum, an Endangered Tropical Plant Species.

Authors:  Misa Takeuchi; Yohei Saito; Masuo Goto; Katsunori Miyake; David J Newman; Barry R O'Keefe; Kuo-Hsiung Lee; Kyoko Nakagawa-Goto
Journal:  J Nat Prod       Date:  2018-08-14       Impact factor: 4.050

3.  Simultaneous HPTLC determination of strychnine and brucine in strychnos nux-vomica seed.

Authors:  Abid Kamal; Y T Kamal; Sayeed Ahmad; F J Ahmad; Kishwar Saleem
Journal:  J Pharm Bioallied Sci       Date:  2012-04

Review 4.  Important poisonous plants in tibetan ethnomedicine.

Authors:  Lijuan Ma; Ronghui Gu; Li Tang; Ze-E Chen; Rong Di; Chunlin Long
Journal:  Toxins (Basel)       Date:  2015-01-14       Impact factor: 4.546

5.  Application of Cornelian Cherry Iridoid-Polyphenolic Fraction and Loganic Acid to Reduce Intraocular Pressure.

Authors:  Dorota Szumny; Tomasz Sozański; Alicja Z Kucharska; Wojciech Dziewiszek; Narcyz Piórecki; Jan Magdalan; Ewa Chlebda-Sieragowska; Robert Kupczynski; Adam Szeląg; Antoni Szumny
Journal:  Evid Based Complement Alternat Med       Date:  2015-06-01       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.